Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

1:15 PM - 1:25 PM PT

325 - Universal Deep Learning Dose Prediction for IMRT Planning
Speaker: Wang, Qingying, MS - University of Texas Southwestern Medical Center, Dallas, TX
1:25 PM - 1:35 PM PT

304 - Genomic Mutation-Driven Stratification of Treatment Response to Stereotactic Spine Radiosurgery in Spinal Metastases
Speaker: Al-Sharfeen, Areeba, BS - MD Anderson Cancer Center, Houston, TX
1:25 PM - 1:35 PM PT

310 - A Phase II Study of Durvalumab and Tremelimumab with Radiation Therapy in Patients with Advanced Hepatocellular Carcinoma and Biliary Tract Cancer
Speaker: Koenig, Julie, MD - Mass General Brigham, Somerville, MA
1:25 PM - 1:35 PM PT

316 - High Bleeding Rates in a Randomized Phase 2 Trial of SBRT with Concurrent and Adjuvant Cetuximab +/- Docetaxel in Previously-Irradiated HNSCC
Speaker: Vera, Alberto, MD - UPMC Cancer Center, Pittsburgh, PA
1:25 PM - 1:35 PM PT

321 - Low-Dose Radiotherapy Modulates Dendritic Cell Metabolism to Reprogram the Tumor Immune Microenvironment
Speaker: Liu, Ningbo, MD, PhD - Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin
1:25 PM - 1:35 PM PT

326 - Plan Quality Reporting of the Phase II Stereotactic MR-Guided Adaptive Radiation Therapy in One Fraction (SMART ONE) Trial
Speaker: Mittauer, Kathryn, PhD - Miami Cancer Institute- Baptist Health South Florida, Miami, FL
1:35 PM - 1:45 PM PT

305 - Temporal Effects of Dose and Fractionation of FLASH and Conventional Irradiation on Hippocampal Neurogenesis and Mechanisms of FLASH-Induced Neuroprotection
Speaker: Katila, Nikita, PhD - Stanford School of Medicine, Stanford, CA
1:35 PM - 1:45 PM PT

311 - Sulfur Colloid SPECT/CT Tracking for Evaluation of Liver Function: Longitudinal Assessment During Radiation Therapy (STELLAR) Prospective Study - Toward Imaging Biomarker-Guided Radiotherapy
Speaker: Apisarnthanarax, Smith, MD - University of Washington Radiation Oncology, Seattle, WA
1:35 PM - 1:45 PM PT

327 - Simplified Imaging-Based Dosimetry of Organs and Inherently Heterogeneous Tumors for <sup>131</sup>I-MIBG Therapy Using Combined Pretherapy <sup>123</sup>I-MIBG and Posttherapy <sup>131</sup>I-MIBG SPECT Imaging
Speaker: Wang, Yiran, PhD - University of California, San Francisco, San Francisco, CA
1:35 PM - 1:45 PM PT

Discussant
Speaker: Mell, Loren, MD, FASTRO - University of California, San Diego, La Jolla, CA
1:35 PM - 1:45 PM PT

Discussant
Speaker: Shiao, Stephen, MD, PhD - Cedars-Sinai Medical Center, Los Angeles, CA
1:45 PM - 1:55 PM PT

328 - A Multicenter, Blinded, Intensity Modulated Proton Therapy Competitive Planning Study for Head and Neck Cancers: The Urgency for Guidelines and Standards
Speaker: Snider, James, MD - Proton International, Tampa, FL